The Diagnostic Role of Arginase-۱, MOC-۳۱, and CDX۲ in the Differentiation of Hepatocellular Carcinoma, Cholangiocarcinoma, and Metastatic Colonic Carcinoma of the Liver

Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 57

This Paper With 11 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_MISJ-10-4_001

تاریخ نمایه سازی: 25 آبان 1402

Abstract:

Background: Hepatocellular carcinoma (HCC) is the most common primary liver cancer. Pathologic differentiation between HCC from metastatic carcinoma and cholangiocarcinoma has critical therapeutic implications. However, it is occasionally challenging and sometimes requires immunohistochemical panels. Recently, Arginase- ۱, MOC-۳۱, and CDX۲ have been introduced for the differentiation of these tumors. This study was conducted to determine the value of expression of Arginase-۱, MOC- ۳۱, and CDX۲ in differentiating primary carcinoma of the liver from cholangiocarcinoma and metastatic adenocarcinoma to the liver. Methods: ۵۰ cases of HCC, ۲۰ cases of metastatic colonic carcinoma to the liver, and ۱۰ cases of cholangiocarcinoma were evaluated for immunohistochemical expression of Arginase-۱, MOC-۳۱, and CDX۲. Results: Arginase-۱ was positive in ۴۵ (۹۰%) of HCC cases and negative in metastatic carcinoma and cholangiocarcinoma cases. MOC-۳۱ was positive in ۱۹ (۹۵%) of metastatic colonic adenocarcinoma cases and ۱۰ (۱۰۰%) of cholangiocarcinoma cases, while it was negative in HCC cases. CDX۲ was positive in ۱۸ (۹۰%) of metastatic carcinoma cases while it was negative in cholangiocarcinoma cases. The sensitivity of Arginase-۱ for HCC, MOC-۳۱ for MC, and CDX۲ for metastatic colonic carcinoma in the studied groups was ۹۵%, ۱۰۰%, and ۹۸%, respectively, whereas its specificity was ۱۰۰%, ۹۶.۷%, and ۶۰%, respectively. The difference of Arginase-۱, MOC- ۳۱, and CDX۲ expressions in HCC, cholangiocarcinoma, and metastatic colonic adenocarcinoma were statistically significant (P<۰.۰۰۱). Conclusion: Our study revealed that Arginase-۱, MOC-۳۱, and CDX۲ expression are suitable IHC markers in the differential diagnosis of HCC, cholangiocarcinoma, and metastatic colonic adenocarcinoma.

Authors

Hanaa Atwa

Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Hanan Mohammed

Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Ihab Matar

Surgical Oncology Department, Al -Ahrar Zagazig Teaching Hospital, Zagazig, Egypt

Heba Taha

Medical Oncology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Salem Mohamed

Internal Medicine Department, Gastroenterology and Hepatology Unit, Faculty of Medicine, Zagazig University, Zagazig, Egypt